Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. lowered its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 7.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,143,496 shares of the company's stock after selling 182,007 shares during the period. D. E. Shaw & Co. Inc. owned approximately 2.50% of Pediatrix Medical Group worth $28,123,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust increased its stake in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the last quarter. AlphaQuest LLC boosted its holdings in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. Illinois Municipal Retirement Fund grew its position in shares of Pediatrix Medical Group by 7.8% in the 4th quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company's stock valued at $622,000 after buying an additional 3,411 shares during the last quarter. Finally, MetLife Investment Management LLC raised its stake in Pediatrix Medical Group by 6.8% during the 4th quarter. MetLife Investment Management LLC now owns 53,552 shares of the company's stock worth $703,000 after acquiring an additional 3,419 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Up 1.3%

Pediatrix Medical Group stock opened at $14.63 on Monday. The stock has a 50 day moving average of $13.70 and a two-hundred day moving average of $14.05. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of -12.19, a PEG ratio of 1.74 and a beta of 1.26. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same period last year, the company earned $0.20 earnings per share. The company's revenue for the quarter was down 7.4% on a year-over-year basis. As a group, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MD. Macquarie upped their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday. UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, Truist Financial cut their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.